Takanori Yokoi

Fournier Pharma SA manufactures pharmaceutical products. The firm is also in the engaged in the research, development, production and marketing of molecules. The company has operations in Canada, China, Algeria, Bulgaria, Thailand and Turkey. It was founded in 1880 and is headquartered in Chenôve, France.

Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX.

Kowa Co., Ltd. engages in trading of textiles, machinery, and construction materials. The company also manufactures and sells medicines, medical equipment, and energy saving products. It operates through the following business divisions: Pharmaceutical, Medical Device, Foods, General Trading, Lifestyle Business, and Hospitality. The company was founded on December 25, 1894 and is headquartered in Nagoya, Japan.

Kowa Pharmaceutical Europe Co. Ltd. engages in the manufacture of pharmaceutical products. The company was founded in 1947 and is headquartered in Wokingham, the United Kingdom.

Kowa (Shanghai) Pharma Consulting Co., Ltd. engages in prescription drugs, health products, and medical information consulting. The company was founded on August 24, 2007 and is headquartered in Shanghai, China.

Kowa Holdings Europe AG engages in the acquisition, holding, management, and sale of participations in domestic and foreign companies. It focuses on firms that specialize in research, development, production, trade, as well as sale and wholesale of pharmaceutical and chemical products, fashion, interior design, medical products, and lenses. The company was founded on February 8, 2016 and is headquartered in Zurich, Switzerland.

Kowa Health Care (Shanghai) Import & Export Co., Ltd. engages in the sale of medical equipment. It also offers cosmetics, electronic products, sanitary products, sports goods, and textile products. Its business activities include marketing planning, and management consulting services. The company was founded on August 13, 2012 and is headquartered in Shanghai, China.

Kowa Research Europe Ltd. engages in research and experimental development on social sciences and humanities. The firm develops NK-104, Pitavastatin; K-877, Pemafibrate; K-333, Peretinoin; and K-115, Ripasudil compounds. The company was founded on January 12, 1999 and is headquartered in Wokingham, the United Kingdom.